Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Top Biotech Stocks to Buy Right Now


Approval from the U.S. Food and Drug Administration is a big step in the life of a biotech company. It's the difference between theory and reality, between hopes and money in the bank. FDA approval not only means that a company can start selling its drugs, but also that the company might have a government-sanctioned monopoly (because competitors are kept out unless they, too, can survive the FDA gauntlet).

Here are two companies that are facing imminent judgment from the FDA: Amarin (NASDAQ: AMRN) and Blueprint Medicines (NASDAQ: BPMC). Both of these stocks will be a lot higher, or a lot lower, in 2020. Welcome to biotech stock investing!

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments